Introduction Fatigue can be a serious problem among chronically ill patients, but may be overlooked by other more severe disease symptoms. There is not much evidence on fatigue and quality of life (QoL) in patients with rare bone diseases. Thus, the purpose of the study was to assess and compare the prevalence of fatigue and QoL in rare bone disease patients (RARE), patients with osteoporosis (OPO) and healthy controls (CTRL). Methods This monocentric, cross-sectional study was carried out two years in a hospital affiliated with the Vienna Bone and Growth Center (European Reference Network – ERN BOND). The study comprised four types of RARE: Osteogenesis imperfecta, Hypophosphatasia, X-linked Hypophosphatemia and Ehlers Danlos syndrome. Fatigue was assessed by Fatigue Severity Scale (FSS). A higher score indicates more fatigue severity. Health-related quality of life (HRQoL) was assessed by Short-Form Health Survey (SF-36) including physical component (PCS) and mental component summary scores (MCS), which were calculated and normalised to a general population. A higher score indicates better HRQoL. Age-adjusted ANCOVA was used to assess differences in PCS and MCS between groups. Results In total, 54 RARE patients [Mean age (SD) 47.9 (16.0), 75.9% female], 53 OPO patients [66.7 (9.9), 88.7% female] and 52 controls [50.8 (16.3), 73.1% female] were included. The overall Cronbach's α coefficient of the SF-36 was 0.889 and of the FSS 0.922. There were significant differences in fatigue between the 3 groups (p=0.006). Severe fatigue (FSS≥4) was reported by 38.0% of RARE patients, 20.8% OPO patients and by 11.5% controls. Both scores, PCS and MCS were significantly lower in RARE than OPO (p-value 0.002 and 0.007) and CTRLs (p<0.001 for both). Despite higher age in OPO, no significant differences in PCS and MCS were found between OPO and CTLs. Age-adjusted means (95%CI) of PCS and MCS in RARE were 36.1 (32.4-39.7) and 49.6 (46.2-53.1), in OPO 51.5 (46.4-56.6) and 50.2 (45.3-55.0), CTRL 45.2 (42.0-48.5) and 52.8 (49.8-55.9), respectively. FSS score was negatively correlated with physical and mental component in RARE (ρ=-0.45, p=0.002 and ρ=-0.57, p<0.001, respectively) and OPO patients (ρ=-0.32, p=0.03 and ρ=-0.36, p=0.01, respectively). Discussion The QoL in adult patients with rare bone diseases is lower than compared to osteoporotic and control group. Fatigue has significant negative impact on QoL and it is important to address it when meeting with RARE patients in clinical practice. Keywords rare bone disease, health related quality of life, SF-36, FSS, fatigue Korrespondenzadresse Daniel Arian Kraus, Ludwig Boltzmann Institut für Osteologie, Heinrich-Collin-Straße 30, 1140 Wien, Österreich, E-Mail: daniel.arian.kraus@gmail.com Article published online: 16 June 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany